Analytical Standards Market to reach USD 3.47 Billion by 2032 and grow at a CAGR of 9.36%
The pharmaceutical industry has been producing drugs with more complex molecules and quality standards are gaining importance due to the focus on safety resulting in an ever-increasing need for analytical standards, for drug development all through the product life cycle up to regulatory compliance. As more pharma companies invest in researching and developing the environmental safety of new drugs for treating chronic life-related diseases this trend is also forecast to have a substantial impact on market growth.